iBio (IBIO) Preferred Dividend Payments (2017 - 2021)
iBio (IBIO) posted quarterly Preferred Dividend Payments of $22000.0 for Q4 2021, down 66.15% year-over-year from $65000.0 in Q4 2020, and down 66.67% quarter-over-quarter from $66000.0 in Q3 2021.
iBio (IBIO) Preferred Dividend Payments (2017 - 2021) Analysis & Trends
iBio (IBIO) has reported Preferred Dividend Payments for 5 consecutive years, with $22000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Dividend Payments fell 66.15% year-over-year to $22000.0; the TTM figure through Sep 2022 stood at $22000.0 (down 91.54% YoY), while the FY2022 annual figure was $88000.0, down 66.15% from the prior year.
- Preferred Dividend Payments declined to $22000.0 in Q4 2021 per IBIO's latest filing, from $66000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $66000.0 in Q3 2017 and bottomed at $22000.0 in Q4 2021.
- Historically, Preferred Dividend Payments has averaged $60950.0 across 5 years, with a median of $65000.0 in 2017.
- Annual changes were most pronounced in 2018 — Preferred Dividend Payments soared 146.15% — and 2021, when it plunged 66.15%.
- iBio's Preferred Dividend Payments stood at $65000.0 in 2017, then changed by 0.0% to $65000.0 in 2018, then changed by 0.0% to $65000.0 in 2019, then changed by 0.0% to $65000.0 in 2020, then slumped by 66.15% to $22000.0 in 2021.
- Business Quant data shows IBIO's Preferred Dividend Payments at $22000.0 in Q4 2021, $66000.0 in Q3 2021, and $65000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 66,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Sep 30, 2020 | 66,000.00 |
| Jun 30, 2020 | 65,000.00 |
| Mar 31, 2020 | 65,000.00 |
| Dec 31, 2019 | 65,000.00 |
| Sep 30, 2019 | 66,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 64,000.00 |
| Dec 31, 2018 | 65,000.00 |
| Sep 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 64,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Sep 30, 2017 | 66,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Mar 31, 2017 | 26,000.00 |